NNOX logo

Nano-X Imaging (NNOX) Company Overview

Profile

Full Name:

Nano-X Imaging Ltd.

Sector:

Healthcare

Country:

Israel

IPO:

August 21, 2020

Indexes:

Not included

Description:

Nano-X Imaging (NNOX) is a medical technology company focused on developing innovative imaging solutions. Their goal is to make medical imaging more accessible and affordable, using advanced technology to improve diagnostics and patient care. They aim to revolutionize the way imaging is done in healthcare.

Events Calendar

Earnings

Next earnings date:

Apr 1, 2025

Recent quarterly earnings:

Nov 21, 2024

Recent annual earnings:

Apr 1, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 6, 25 D. Boral Capital
Buy
Dec 6, 24 Cantor Fitzgerald
Overweight
Nov 26, 24 Cantor Fitzgerald
Overweight
Sep 23, 24 Cantor Fitzgerald
Overweight
May 31, 24 Cantor Fitzgerald
Overweight
May 30, 24 Cantor Fitzgerald
Overweight
May 29, 24 Cantor Fitzgerald
Overweight
Apr 19, 21 Ladenburg Thalmann
Buy
Feb 1, 21 Cantor Fitzgerald
Overweight
Sep 15, 20 Oppenheimer
Perform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Are Business Services Stocks Lagging NanoX Imaging (NNOX) This Year?
Are Business Services Stocks Lagging NanoX Imaging (NNOX) This Year?
Are Business Services Stocks Lagging NanoX Imaging (NNOX) This Year?
NNOX
zacks.comJanuary 3, 2025

Here is how Nano-X Imaging Ltd. (NNOX) and VerifyMe, Inc. (VRME) have performed compared to their sector so far this year.

Here's Why Nanox Stock Went Up Today
Here's Why Nanox Stock Went Up Today
Here's Why Nanox Stock Went Up Today
NNOX
fool.comDecember 5, 2024

Shares of medical imaging company Nano-X Imaging (NNOX 3.02%) -- commonly referred to as Nanox -- went up on Thursday after some pretty substantial news broke regarding regulatory clearance. At 10:50 a.m.

Nano-X Imaging Ltd. (NNOX) Q3 2024 Earnings Call Transcript
Nano-X Imaging Ltd. (NNOX) Q3 2024 Earnings Call Transcript
Nano-X Imaging Ltd. (NNOX) Q3 2024 Earnings Call Transcript
NNOX
seekingalpha.comNovember 21, 2024

Nano-X Imaging Ltd. (NASDAQ:NNOX ) Q3 2024 Earnings Conference Call November 21, 2024 8:30 AM ET Company Participants Mike Cavanaugh - IR Erez Meltzer - CEO Ran Daniel - CFO Conference Call Participants Ross Osborn - Cantor Fitzgerald Jeffrey Cohen - Ladenburg Scott Henry - Alliance Global Operator Ladies and gentlemen, thank you for standing by.

Nanox to Report Third Quarter and Financial Results on November 21, 2024
Nanox to Report Third Quarter and Financial Results on November 21, 2024
Nanox to Report Third Quarter and Financial Results on November 21, 2024
NNOX
globenewswire.comNovember 11, 2024

PETACH TIKVA, Israel, Nov. 11, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended September 30, 2024, before market open on Thursday, November 21, 2024. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.

Nanox to Participate in Upcoming Investor Conference in September 2024
Nanox to Participate in Upcoming Investor Conference in September 2024
Nanox to Participate in Upcoming Investor Conference in September 2024
NNOX
globenewswire.comSeptember 10, 2024

PETACH TIKVA, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that Company management will participate in an investor conference in the month of September 2024:

Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium
Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium
Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium
NNOX
globenewswire.comAugust 21, 2024

HealthCCSng V2.0 i ntroduces additional ‘ zero calcium ' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC d etection c ategory output

Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update
Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update
Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update
NNOX
globenewswire.comAugust 20, 2024

Accelerated the deployment of Nanox ARC in the US market, Submitted a new 510k application to the FDA to expand Nanox.ARC indications to include  general use, including chest  Nanox.AI Receives FDA 510K Clearance for HealthCCSng V 2.0, upgraded version of its AI Cardiac Solution  Management to host conference call and webcast Tuesday, August 20, 2024 at 8:30 AM ET PETAH TIKVA, Israel, Aug. 20, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the second quarter ended June 30, 2024 and provided a business update. Recent Highlights: Generated $2.7 million in revenue in the second quarter of 2024, compared to $2.6 million in the second quarter of 2023.

These Nvidia-Backed Artificial Intelligence (AI) Stocks Could Soar 73% to 89% Higher, According to Wall Street
These Nvidia-Backed Artificial Intelligence (AI) Stocks Could Soar 73% to 89% Higher, According to Wall Street
These Nvidia-Backed Artificial Intelligence (AI) Stocks Could Soar 73% to 89% Higher, According to Wall Street
NNOX
fool.comJuly 12, 2024

Nano-X Imaging is especially popular with analysts. Recursion Pharmaceuticals plans to report results from seven clinical studies over the next 18 months.

Is NanoX Imaging (NNOX) Outperforming Other Business Services Stocks This Year?
Is NanoX Imaging (NNOX) Outperforming Other Business Services Stocks This Year?
Is NanoX Imaging (NNOX) Outperforming Other Business Services Stocks This Year?
NNOX
zacks.comJuly 8, 2024

Here is how Nano-X Imaging Ltd. (NNOX) and Parsons (PSN) have performed compared to their sector so far this year.

Data Supporting Nanox.AI Cardiac Solution to Be Presented at 19th Annual Meeting of the Society of Cardiovascular Computed Tomography
Data Supporting Nanox.AI Cardiac Solution to Be Presented at 19th Annual Meeting of the Society of Cardiovascular Computed Tomography
Data Supporting Nanox.AI Cardiac Solution to Be Presented at 19th Annual Meeting of the Society of Cardiovascular Computed Tomography
NNOX
globenewswire.comJune 25, 2024

PETACH TIKVA, Israel, June 25, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that data from five studies supporting the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox AI, will be presented at the 19th Annual Meeting of the Society of Cardiovascular Computed Tomography (SCCT), being held July 18-21 in Washington, D.C.

FAQ

  • What is the ticker symbol for Nano-X Imaging?
  • Does Nano-X Imaging pay dividends?
  • What sector is Nano-X Imaging in?
  • What industry is Nano-X Imaging in?
  • What country is Nano-X Imaging based in?
  • When did Nano-X Imaging go public?
  • Is Nano-X Imaging in the S&P 500?
  • Is Nano-X Imaging in the NASDAQ 100?
  • Is Nano-X Imaging in the Dow Jones?
  • When was Nano-X Imaging's last earnings report?
  • When does Nano-X Imaging report earnings?
  • Should I buy Nano-X Imaging stock now?

What is the ticker symbol for Nano-X Imaging?

The ticker symbol for Nano-X Imaging is NASDAQ:NNOX

Does Nano-X Imaging pay dividends?

No, Nano-X Imaging does not pay dividends

What sector is Nano-X Imaging in?

Nano-X Imaging is in the Healthcare sector

What industry is Nano-X Imaging in?

Nano-X Imaging is in the Medical Devices industry

What country is Nano-X Imaging based in?

Nano-X Imaging is headquartered in Israel

When did Nano-X Imaging go public?

Nano-X Imaging's initial public offering (IPO) was on August 21, 2020

Is Nano-X Imaging in the S&P 500?

No, Nano-X Imaging is not included in the S&P 500 index

Is Nano-X Imaging in the NASDAQ 100?

No, Nano-X Imaging is not included in the NASDAQ 100 index

Is Nano-X Imaging in the Dow Jones?

No, Nano-X Imaging is not included in the Dow Jones index

When was Nano-X Imaging's last earnings report?

Nano-X Imaging's most recent earnings report was on Nov 21, 2024

When does Nano-X Imaging report earnings?

The next expected earnings date for Nano-X Imaging is Apr 1, 2025

Should I buy Nano-X Imaging stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions